UroToday4d
Palliative Care for Pediatric Urology - Beyond the Abstract
As defined by the World Health Organization, palliative care is a medical specialty that aims to improve the quality of life of any patient, regardless of age, and their families who face ...
UroToday4d
The Effect of Enhanced Recovery After Surgery on Oncologic Outcome Following Radical Cystectomy for Urothelial Bladder Carcinoma - Beyond the Abstract
Radical cystectomy is a primary treatment approach for muscle-invasive bladder cancer and certain high-risk non-muscle invasive diseases. Despite its efficacy, it is associated with significant ...
UroToday4d
Competing risk nomogram predicting cause-specific mortality in older patients with testicular germ cell tumors.
Testicular germ cell tumor (TGCT) is the most common type of malignancy in young men, but rarely in older adults. We aimed to construct a competing risk model to predict the prognosis for older ...
UroToday4d
Cytokines in Bladder Pain Syndrome: A Review of the Literature.
Bladder pain syndrome (BPS) is poorly understood with both the aetiology and pathophysiology being unknown. Symptoms overlap with other disorders, such as overactive bladder (OAB) and chronic pelvic ...
UroToday4d
Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances.
Renal cell carcinoma (RCC) is one of the 10 most commonly diagnosed solid tumors. Most RCCs are histologically defined as clear cell, comprising approximately 75% of diagnoses. However, the remaining ...
UroToday4d
Efficiency of bladder-sparing strategies for bladder cancer: an umbrella review.
Bladder preservation (BP) has emerged as a clinical alternative to radical cystectomy (RC) for alleviating the substantial physical and psychological burden imposed on localized bladder cancer ...
UroToday4d
Is the excretory phase necessary to identify upper tract urothelial neoplasms at CT urography? A 10-year population-based study.
To assess the proportion of upper tract urothelial carcinomas (UTUC) that are evident without the excretory phase at CT urography (CTU), and the proportion of potentially avoidable radiation. UTUCs ...
UroToday4d
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Radiotherapy (RT) and long-term androgen deprivation therapy (ltADT; 18-36 mo) is a standard of care in the treatment of high-risk localized/locoregional prostate cancer (HRLPC). We evaluated the ...
UroToday4d
Systematic review of recent advancements in antibody-drug and bicycle toxin conjugates for the treatment of urothelial cancer.
Antibody-drug conjugates and bicycle toxin conjugates represent a tremendous advance in drug delivery technology and have shown great promise in the treatment of urothelial cancer. Previously approved ...
UroToday4d
Agent orange exposure and prostate cancer risk in the million veteran program.
The US government considers veterans to have been exposed to Agent Orange if they served in Vietnam while the carcinogen was in use, and these veterans are often deemed at high risk of prostate cancer ...
UroToday5d
Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient.
The standard treatment paradigm for muscle invasive bladder cancer has been neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy. However, efforts are ongoing to personalize ...
UroToday5d
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.
Upper tract urothelial carcinoma (UTUC) is an aggressive and difficult malignancy to treat. Owing to its rarity and the lack of specific high-level data, management mirrors that of urothelial cancer ...